TrialAssure ads

We're happy to announce that we've found dramatic improvement in accuracy and efficiency in its most challenging, analytically complicated workflows after incorporating agentic AI methodology into our ANONYMIZE® and LINK® AI solutions! ✅ Within ANONYMIZE, agentic workflows support context-sensitive anonymization activities, helping teams manage information that requires more nuanced assessment than straightforward detection and replacement. ✅ For LINK AI, coordinated AI activities support complex medical writing workflows, including the organization of source information, document preparation, and quality review. Read the full story: https://lnkd.in/gQZb8hKc #PharmaNews #BiotechNews #AInews #LifeScienceNews

Media outlet European Pharmaceutical Manufacturer recently shared news that "TrialAssure has announced that its ANONYMIZE platform has been selected by the European Medicines Agency (EMA) as an official anonymisation tool used within the Agency." As the publication quoted: “We are proud to have been selected following the EMA’s evaluation process,” said Prasad M. Koppolu, chief operating officer, TrialAssure. “Anonymisation should be seen as a core capability that needs to scale, stand up to scrutiny, and support real transparency. It also has to work in real regulatory environments, be auditable, and preserve the value of the data. That is exactly what we have built, and we are proud to see that recognised at this level.” Read more here and send us a message with any questions: https://lnkd.in/d5Mk63Sb #EMA #Anonymization #Anonymisation #LifeSciences #Biotech #Pharma #DrugDevelopment #EU

We’re proud to announce that TrialAssure® ANONYMIZE® has been selected by the European Medicines Agency (EMA) as an official anonymisation tool used within the Agency. EMA will use TrialAssure ANONYMIZE to redact clinical documents, including dossiers submitted by marketing authorisation holders, to protect the identity and privacy of global clinical trial participants. These documents will be posted publicly in accordance with transparency initiatives such as EMA Policy 0043. The selection follows a structured vendor evaluation and market research process conducted by EMA to identify scalable, compliant solutions capable of supporting the region’s increasing transparency and data protection requirements. Read the full announcement: https://lnkd.in/gmZdF5TM #ClinicalTrialTransparency #DataAnonymisation #PatientPrivacy

Reduce data, document, and image anonymization time by up to 80% with AI built for life sciences! See how TrialAssure ANONYMIZE helps sponsors accelerate review, improve consistency, and protect sensitive information. Schedule your personalized demo today: https://lnkd.in/gCpTGnfT

Every hour spent manually anonymizing documents, data, and images is an hour your experts aren't moving studies forward. See how TrialAssure ANONYMIZE helps sponsors accelerate review, improve consistency, and protect sensitive information. Request your personalized demo today! Start here: https://lnkd.in/gCpTGnfT

Reduce data, document, and image anonymization time by up to 80% with AI built for life sciences! See how TrialAssure ANONYMIZE helps sponsors accelerate review, improve consistency, and protect sensitive information. Schedule your personalized demo today: https://lnkd.in/gCpTGnfT